对精神分裂症多重抗精神病药物治疗的再评估：社会康复的更广阔视角的回应。

IF 5 3区医学 Q1 CLINICAL NEUROLOGY

Psychiatry and Clinical Neurosciences Pub Date : 2025-04-29 DOI:10.1111/pcn.13834

Yuhei Mori, Risa Shishido, Mizuki Hino, Akiko Sato, Atsuko Nagaoka, Hiroshi Hoshino, Masataka Hatano, Yuto Hosogai, Itaru Miura, Yasuto Kunii

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Response to [Reevaluating Antipsychotic Polypharmacy in Schizophrenia: A Broader Perspective on Social Recovery].

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Psychiatry and Clinical Neurosciences 医学-精神病学

CiteScore

7.40

自引率

4.20%

发文量

181

审稿时长

6-12 weeks

期刊介绍： PCN (Psychiatry and Clinical Neurosciences) Publication Frequency: Published 12 online issues a year by JSPN Content Categories: Review Articles Regular Articles Letters to the Editor Peer Review Process: All manuscripts undergo peer review by anonymous reviewers, an Editorial Board Member, and the Editor Publication Criteria: Manuscripts are accepted based on quality, originality, and significance to the readership Authors must confirm that the manuscript has not been published or submitted elsewhere and has been approved by each author